Professur für Translationale Frauenheilkunde und Geburtshilfe

Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact (2025) Hübner H, Wimberger P, Laakmann E, Ruckhäberle E, Rübner M, Lehle S, Uhrig S, et al. Journal article The Role of Artificial Intelligence in Gynecologic Oncology Decision-Making: A Feasibility Study (2025) Psilopatis I, Sipulina N, Stübs F, Heindl F, Pöschke P, Bader S, Krückel A, et al. Journal article Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025) Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, et al. Journal article Genome-Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical Cancer (2025) Beckhaus T, Kachuri L, Nakase T, Schürmann P, Eisenblätter R, Geerts M, Böhmer G, et al. Journal article A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial (2025) Hortobagyi GN, Lacko A, Sohn J, Cruz F, Ruiz Borrego M, Manikhas A, Hee Park Y, et al. Journal article Personal Profiling im Bereich der Senologie (2025) Behrens A, Beckmann M, Fasching P, Hübner H, Emons J Journal article Overall Survival in Metastatic Breast Cancer Patients: Real-World Data from 1, 000 Patients Treated at the NCT Heidelberg between 2014 and 2022 (2025) Michel LL, Feisst M, Thewes V, Jäger D, Hartkopf AD, Brucker SY, Uhrig S, et al. Journal article Validation of the Questionnaire for the Structured Assessment of the Use of Complementary Medicine Methods and Procedures in Patients from the S3 Guideline Complementary Medicine in Oncology and Practical Use of it in Patients with Gynecological Cancer (2025) Seitz K, Theuser AK, Hack C, Fasching P, Emons J, Brückner L, Au K, et al. Journal article Evaluating the potential of ChatGPT for patient identification in clinical breast cancer trials (2025) Krückel A, Fasching P, Schleicher O, Gocke J, Brückner L, Seitz K, Häberle L, et al. Journal article Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2− Advanced Breast Cancer (2025) Sammons S, Yardley DA, Sharma P, Gadi VK, Pegram M, Pathak P, Hu H, et al. Journal article